To be considered for tirzepatide treatment, clients should meet the following requirements: A Body Mass Index (BMI) of 30 kg/m or higher, qualifying as obesity, or a BMI of 27 kg/m or higher if accompanied by at least one weight-related health condition, such as Type 2 diabetes, hypertension, dyslipidemia (high cholesterol or triglycerides), obstructive sleep apnea, or nonalcoholic fatty liver disease (NAFLD)
African American individuals (and other susceptible minorities) are at increased risk for type 2 diabetes
Protocol eight: supplement strategically Targeted supplementation can address specific metabolic bottlenecks that contribute to stalls
The first is the deterioration of selenium-dependent antioxidant capacity, which damages DNA and cell membranes (30)
This intricate communication helps individuals regulate their appetite, fostering a healthier relationship with food